Glaxosmithkline Pharmaceuticals Ltd. · Q3FY20
Result on 4 Feb 2020; judged on 10 Oct 2026. No read was made before it — it is recorded for the base rate. The company's page →
unreadverdict
—the read
-20.7%vs market, 10 sessions
-16.4%T+1
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹1,646.35the base every move below is measured from
T+1-16.4%
T+10-18.3%market +2.4%
vs market-20.7%no sector index mapped
Best close after-12.1%traded as high as -6.5% on 5 Feb
Worst close after-21.0%traded as low as -22.2% on 11 Feb
Run-up, 30 sessions—into the result
52-week range3% below high3% above low
- Delivery share
- -8.1 points in the fortnight before, against the month before that
- Volume
- 0.54× its prior month, in the fortnight before
- Habit held
- unknown — could not be checked
- Announced
- Tue, during market hours — the reaction session is the announcement day
- Peers reporting
- 2 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Went into the result within 5% of its 52-week low.
- Announced during market hours, so the reaction session is the announcement day itself.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY HEALTHCARE INDEX from base |
|---|---|---|---|---|---|---|---|---|---|
| T-23 | 1 Jan | 1,626.00 | 1,651.50 | 1,614.10 | 1,631.85 | — | -0.88% | +4.05% | — |
| T-22 | 2 Jan | 1,645.00 | 1,645.65 | 1,615.35 | 1,624.45 | -0.45% | -1.33% | +4.91% | — |
| T-21 | 3 Jan | 1,624.00 | 1,630.00 | 1,602.00 | 1,611.10 | -0.82% | -2.14% | +4.43% | — |
| T-20 | 6 Jan | 1,619.60 | 1,619.60 | 1,589.00 | 1,592.10 | -1.18% | -3.30% | +2.44% | — |
| T-19 | 7 Jan | 1,609.95 | 1,655.00 | 1,605.00 | 1,628.85 | +2.31% | -1.06% | +2.95% | — |
| T-18 | 8 Jan | 1,605.05 | 1,644.00 | 1,602.45 | 1,635.50 | +0.41% | -0.66% | +2.71% | — |
| T-17 | 9 Jan | 1,648.00 | 1,653.10 | 1,623.05 | 1,640.65 | +0.31% | -0.35% | +4.34% | — |
| T-16 | 10 Jan | 1,640.65 | 1,664.95 | 1,622.00 | 1,626.90 | -0.84% | -1.18% | +4.69% | — |
| T-15 | 13 Jan | 1,626.50 | 1,640.00 | 1,616.55 | 1,627.90 | +0.06% | -1.12% | +5.31% | — |
| T-14 | 14 Jan | 1,629.00 | 1,635.15 | 1,618.50 | 1,627.65 | -0.02% | -1.14% | +5.59% | — |
| T-13 | 15 Jan | 1,629.00 | 1,651.00 | 1,618.05 | 1,625.60 | -0.13% | -1.26% | +5.43% | — |
| T-12 | 16 Jan | 1,644.85 | 1,657.00 | 1,625.10 | 1,629.50 | +0.24% | -1.02% | +5.53% | — |
| T-11 | 17 Jan | 1,634.80 | 1,647.00 | 1,618.50 | 1,627.85 | -0.10% | -1.12% | +5.50% | — |
| T-10 | 20 Jan | 1,630.00 | 1,647.00 | 1,623.25 | 1,630.20 | +0.14% | -0.98% | +4.41% | — |
| T-9 | 21 Jan | 1,631.00 | 1,632.50 | 1,616.25 | 1,623.35 | -0.42% | -1.40% | +3.95% | — |
| T-8 | 22 Jan | 1,624.80 | 1,634.00 | 1,618.00 | 1,621.50 | -0.11% | -1.51% | +3.41% | — |
| T-7 | 23 Jan | 1,628.95 | 1,639.80 | 1,622.00 | 1,629.90 | +0.52% | -1.00% | +4.04% | — |
| T-6 | 24 Jan | 1,635.00 | 1,663.50 | 1,627.35 | 1,639.30 | +0.58% | -0.43% | +4.62% | — |
| T-5 | 27 Jan | 1,645.00 | 1,718.00 | 1,644.95 | 1,675.60 | +2.21% | +1.78% | +3.51% | — |
| T-4 | 28 Jan | 1,680.00 | 1,715.00 | 1,677.00 | 1,686.50 | +0.65% | +2.44% | +2.97% | — |
| T-3 | 29 Jan | 1,699.95 | 1,748.00 | 1,684.70 | 1,696.15 | +0.57% | +3.02% | +3.60% | — |
| T-2 | 30 Jan | 1,690.10 | 1,709.70 | 1,665.30 | 1,674.90 | -1.25% | +1.73% | +2.80% | — |
| T-1 | 31 Jan | 1,694.00 | 1,694.00 | 1,655.00 | 1,665.40 | -0.57% | +1.16% | +2.17% | — |
| base | 3 Feb | 1,645.00 | 1,678.30 | 1,611.25 | 1,646.35 | -1.14% | +0.00% | +0.00% | — |
| T+1 | 4 Feb result | 1,520.00 | 1,522.00 | 1,425.05 | 1,447.55 | -12.08% | -12.08% | +2.32% | — |
| T+2 | 5 Feb | 1,434.10 | 1,538.80 | 1,365.00 | 1,376.50 | -4.91% | -16.39% | +3.26% | — |
| T+3 | 6 Feb | 1,390.00 | 1,400.00 | 1,327.10 | 1,342.95 | -2.44% | -18.43% | +3.67% | — |
| T+4 | 7 Feb | 1,351.05 | 1,378.00 | 1,342.50 | 1,356.45 | +1.01% | -17.61% | +3.33% | — |
| T+5 | 10 Feb | 1,358.00 | 1,363.60 | 1,296.15 | 1,301.40 | -4.06% | -20.95% | +2.76% | — |
| T+6 | 11 Feb | 1,302.00 | 1,354.00 | 1,280.05 | 1,322.50 | +1.62% | -19.67% | +3.42% | — |
| T+7 | 12 Feb | 1,333.95 | 1,333.95 | 1,297.40 | 1,306.05 | -1.24% | -20.67% | +4.21% | — |
| T+8 | 13 Feb | 1,313.00 | 1,349.95 | 1,300.00 | 1,343.90 | +2.90% | -18.37% | +3.99% | — |
| T+9 | 14 Feb | 1,353.80 | 1,358.80 | 1,327.00 | 1,335.95 | -0.59% | -18.85% | +3.46% | — |
| T+10 | 17 Feb | 1,334.90 | 1,334.90 | 1,305.00 | 1,317.05 | -1.41% | -20.00% | +2.89% | — |
| T+11 | 18 Feb | 1,321.10 | 1,350.00 | 1,319.00 | 1,344.90 | +2.11% | -18.31% | +2.43% | — |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.